Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial
Pieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Heart Journal (2021) Vol. 42, Iss. 48, pp. 4905-4914
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Iron deficiency and cardiovascular disease
Gianluigi Savarese, Stephan von Haehling, Javed Butler, et al.
European Heart Journal (2022) Vol. 44, Iss. 1, pp. 14-27
Open Access | Times Cited: 120
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis
Fraser J Graham, Pierpaolo Pellicori, Paul R. Kalra, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 4, pp. 528-537
Open Access | Times Cited: 81
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Ridha I.S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 104
How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
Milton Packer
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2287-2296
Open Access | Times Cited: 47
Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis
Husam M. Salah, Gianluigi Savarese, Giuseppe Rosano, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 2, pp. 1473-1480
Open Access | Times Cited: 39
Iron deficiency and supplementation in heart failure
Samira Lakhal‐Littleton, John G.F. Cleland
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 463-486
Closed Access | Times Cited: 13
Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action
P. Cacoub, Gabriel Choukroun, Alain Cohen‐Solal, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 4, pp. 542-556
Open Access | Times Cited: 32
Harnessing nanotechnology for cardiovascular disease applications - a comprehensive review based on bibliometric analysis
Zaiyong Zheng, Shuang Zhu, Mingming Lv, et al.
Nano Today (2022) Vol. 44, pp. 101453-101453
Closed Access | Times Cited: 31
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications
Pieter Martens, Shilin Yu, Brett Larive, et al.
European Heart Journal (2023) Vol. 44, Iss. 22, pp. 1979-1991
Open Access | Times Cited: 17
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Treatment of Iron Deficiency in Heart Failure
Aamir Shamsi, Antonio Cannatà, Susan Piper, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 7, pp. 649-661
Open Access | Times Cited: 12
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Inês Falcão‐Pires, Ana Filipa Ferreira, Fábio Trindade, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1454-1479
Open Access | Times Cited: 4
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
Johann Bauersachs, Rudolf A. de Boer, JoAnn Lindenfeld, et al.
European Heart Journal (2021) Vol. 43, Iss. 5, pp. 367-376
Open Access | Times Cited: 24
The effect of intravenous ferric carboxymaltose on right ventricular function – insights from the IRON‐CRT trial
Pieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 1106-1113
Open Access | Times Cited: 18
Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
Hana Manceau, Jérôme Ausseil, Damien Masson, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3214-3214
Open Access | Times Cited: 18
Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure
Pieter Martens, Silvio Nunes Augusto, J. Emanuel Finet, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 10, pp. 1365-1376
Open Access | Times Cited: 10
Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure
Pieter Martens, Silvio Nunes Augusto, Wilfried Müllens, et al.
JACC Heart Failure (2023) Vol. 12, Iss. 3, pp. 525-536
Closed Access | Times Cited: 10
Diagnosis and treatment of iron deficiency in chronic heart failure
Moritz Messner, Gerhard Pölzl, Christopher Adlbrecht, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S3, pp. 143-156
Open Access
The Effect of Iron Deficiency on Cardiac Function and Structure in Heart Failure with Reduced Ejection Fraction
Pieter Martens
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 15
Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials
Ziwei Mei, Jun Chen, Songmei Luo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106345-106345
Closed Access | Times Cited: 15
Systematic review and meta‐analysis of intravenous iron therapy for adults with non‐anaemic iron deficiency: An abridged Cochrane review
Cory Dugan, Katerina Cabolis, Lachlan F. Miles, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 6, pp. 2637-2649
Open Access | Times Cited: 15
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function
Iain C. Macdougall, Piotr Ponikowski, Austin G. Stack, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 9, pp. 1124-1134
Open Access | Times Cited: 9
Intravenous Iron for Acute and Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) Patients with Iron Deficiency: An Updated Systematic Review and Meta-Analysis
Ahmed K. Awad, Mahmoud Shaaban Abdelgalil, Ahmed R. Gonnah, et al.
Clinical Medicine (2024) Vol. 24, Iss. 3, pp. 100211-100211
Open Access | Times Cited: 3
Intravenous iron therapy for heart failure and iron deficiency: An updated meta‐analysis of randomized clinical trials
Mushood Ahmed, Aimen Shafiq, Hira Javaid, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 3
Iron homeostasis in the heart: Molecular mechanisms and pharmacological implications
Jiawei Zhang, Yijing Song, You Li, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 174, pp. 15-24
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top